Cancer of the breast without ER, PR, HER2 expression, 48 cases (1.5mm), set 1HumanBreastBreastMalignant |
|
BRC964 |
Pantomics |
1 |
EUR 519 |
Breast Elisa Laboratories manufactures the elisa for the detention of er and pr in breast cancer reagents distributed by Genprice. The Elisa For The Detention Of Er And Pr In Breast Cancer reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact breast elisa. Other Elisa products are available in stock. Specificity: Elisa Category: For Group: The Detention
Advanced stage breast cancer and normal breast tissue array |
|
TissueArray |
each |
EUR 306 |
|
Description: Advanced stage breast cancer and normal breast tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), ER\PR\HER-2\Ki-67 marker, 119 cases/119 cores, (1.5mm) |
Breast Tumor Tissue Array - Duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal an |
|
Biochain |
5 slides |
EUR 1657.2 |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Breast Tumor Tissue Array - Duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal an |
|
Biochain |
5 slides |
EUR 1657.2 |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Cancer of the breast, 75 cases (1.1mm), set 1HumanBreastBreastMalignant |
|
Pantomics |
1 |
EUR 289 |
Cancer of the breast, 75 cases (1.1mm), set 10HumanBreastBreastMalignant |
|
Pantomics |
1 |
EUR 289 |
Cancer of the breast, 75 cases (1.1mm), set 11HumanBreastBreastMalignant |
|
Pantomics |
1 |
EUR 289 |
Cancer of the breast, 75 cases (1.1mm), set 12HumanBreastBreastMalignant |
|
Pantomics |
1 |
EUR 289 |
The Detention information
Cancer of the breast, 75 cases (1.1mm), set 13HumanBreastBreastMalignant |
|
BRC15013 |
Pantomics |
1.1mm |
EUR 289 |
ELISA Kit for Breast Cancer Susceptibility Protein 2 (BRCA2) |
|
SEB364Hu |
Cloud-Clone |
96Т |
EUR 665 |
|
|
ELISA Kit for Breast Cancer Susceptibility Protein 2 (BRCA2) |
|
SEB364Mu |
Cloud-Clone |
96Т |
EUR 684 |
|
|
ELISA Kit for Breast Cancer Susceptibility Protein 1 (BRCA1) |
|
SEB376Hu |
Cloud-Clone |
96Т |
EUR 665 |
|
|
ELISA Kit for Human Breast cancer metastasis-suppressor 1 |
|
E9631h |
EIAab |
96T |
EUR 441.6 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (PE) |
|
MBS6156710-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (PE) |
|
MBS6156710-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (AP) |
|
MBS6130195-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (AP) |
|
MBS6130195-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) APC |
|
MBS6135498-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) APC |
|
MBS6135498-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (FITC) |
|
MBS6146104-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (FITC) |
|
MBS6146104-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP) |
|
MBS6151407-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP) |
|
MBS6151407-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
BCAS1, CT (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) |
|
MBS646867-005mg |
MyBiosource |
0.05mg |
EUR 875 |
BCAS1, CT (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) |
|
MBS646867-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3780 |